80 related articles for article (PubMed ID: 6930768)
1. [The pharmacology of sulfinpyrazone (Anturan)].
Rüegg M
Wien Med Wochenschr Suppl; 1980; 61():3-8. PubMed ID: 6930768
[No Abstract] [Full Text] [Related]
2. Proceedings: The effect of sulphinpyrazone (Anturan) on immunologically derived thrombocytopenia and on platelet survival.
White AM; Butler KD
Thromb Diath Haemorrh; 1975 Nov; 34(2):553-4. PubMed ID: 128152
[No Abstract] [Full Text] [Related]
3. [Effect of sulfinpyrazone on the platelet function and in experimental thrombosis].
Haas S; Ketterl R; Blümel G
Fortschr Med; 1981 Jan; 99(4):113-8. PubMed ID: 7274948
[TBL] [Abstract][Full Text] [Related]
4. Long-lasting inhibition of platelet prostaglandin but normal vascular prostacyclin generation following sulphinpyrazone administration to rats.
Livio M; Villa S; de Gaetano G
J Pharm Pharmacol; 1980 Oct; 32(10):718-9. PubMed ID: 6107351
[No Abstract] [Full Text] [Related]
5. Letter: Action of sulfinpyrazon.
de Jonge H; Loeliger EA
Thromb Diath Haemorrh; 1975 Jun; 33(3):674. PubMed ID: 1154325
[No Abstract] [Full Text] [Related]
6. [Summary of the clinical papers on sulfinpyrazone (Anturan) under discussion with a preview of the current study program].
Fontanilles F
Wien Med Wochenschr Suppl; 1980; 61():23-4. PubMed ID: 6930767
[No Abstract] [Full Text] [Related]
7. [Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
Birgens HS; Hansen MS
Ugeskr Laeger; 1980 Jan; 142(5):306-9. PubMed ID: 6986701
[No Abstract] [Full Text] [Related]
8. [Effect of heparin, acetylsalicylic acid and sulfinpyrazone on thrombocyte morphology].
Fritsche HM; Ketterl R; Leimgruber D; Blümel G
Med Welt; 1979 Mar; 30(10):365-9. PubMed ID: 763120
[No Abstract] [Full Text] [Related]
9. The effect of sulfinpyrazone on platelet economy and thrombus formation in rabbits.
Mustard JF; Rowsell HC; Smythe HA; Senyi A; Murphy EA
Blood; 1967 Jun; 29(6):859-66. PubMed ID: 6029001
[No Abstract] [Full Text] [Related]
10. Platelets, cardiac valves and sulphinpyrazone.
Loeliger EA
Thromb Haemost; 1982 Apr; 47(2):189. PubMed ID: 7101242
[No Abstract] [Full Text] [Related]
11. Prevention of thrombosis with antiplatelet drugs.
Kahn SB
Am Fam Physician; 1980 May; 21(5):166-8. PubMed ID: 7377074
[No Abstract] [Full Text] [Related]
12. Antiplatelet therapy.
Turpie AG
Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
[No Abstract] [Full Text] [Related]
13. On the inhibiting effect of sulfinpyrazone on platelets.
Cortellaro M; Polli EE
Thromb Res; 1979; 15(5-6):895-6. PubMed ID: 494186
[No Abstract] [Full Text] [Related]
14. Platelets and coronary heart disease: therapy update.
Mehta JL
Geriatrics; 1982 May; 37(5):129-34, 139. PubMed ID: 7040169
[No Abstract] [Full Text] [Related]
15. Sulphinpyrazone and indomethacin for inhibition of platelet prostaglandin synthesis.
Huijgens PC; van den Berg CA; Imandt LM; Langenhuijsen MM
Thromb Res; 1981 Nov; 24(3):267-70. PubMed ID: 7336383
[No Abstract] [Full Text] [Related]
16. Sulfinpyrazone: relationship between dose, kinetics, plasma concentrations and biological effects.
Buchanan MR
Thromb Res Suppl; 1983; 4():89-92. PubMed ID: 6356467
[No Abstract] [Full Text] [Related]
17. The effect of sulphinpyrazone and other drugs on the platelet response during the acute phase of the active Arthus reaction in guinea pigs.
Butler KD; Pay GF; Roberts JM; White AM
Thromb Res; 1979; 15(3-4):319-40. PubMed ID: 158844
[No Abstract] [Full Text] [Related]
18. Drug interactions and antiplatelet agents.
Ahmad S
Am J Cardiol; 1980 Aug; 46(2):341. PubMed ID: 7405849
[No Abstract] [Full Text] [Related]
19. Influence of sulphinpyranzone (Anturan) on thrombo-elastography.
Leutenegger F; Michot F
J Int Med Res; 1978; 6(2):133-5. PubMed ID: 631414
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of warfarin action by sulphinpyrazone.
Bailey RR; Reddy J
Lancet; 1980 Feb; 1(8162):254. PubMed ID: 6101699
[No Abstract] [Full Text] [Related]
[Next] [New Search]
